Northwest & Ethical Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22M Sell
118,793
-34,522
-23% -$6.4M 0.55% 58
2025
Q1
$32.1M Sell
153,315
-42,135
-22% -$8.83M 0.87% 21
2024
Q4
$34.7M Buy
195,450
+6,375
+3% +$1.13M 0.94% 15
2024
Q3
$37.3M Buy
189,075
+10,937
+6% +$2.16M 0.99% 15
2024
Q2
$30.6M Sell
178,138
-312
-0.2% -$53.5K 0.88% 21
2024
Q1
$32.5M Buy
178,450
+31,461
+21% +$5.73M 0.94% 20
2023
Q4
$22.8M Sell
146,989
-187
-0.1% -$29K 0.7% 39
2023
Q3
$21.9M Sell
147,176
-41,697
-22% -$6.22M 0.74% 34
2023
Q2
$25.4M Buy
188,873
+42,294
+29% +$5.7M 0.82% 30
2023
Q1
$23.4M Buy
146,579
+1,480
+1% +$236K 0.78% 32
2022
Q4
$23.4M Buy
145,099
+32,952
+29% +$5.33M 0.81% 31
2022
Q3
$15.1M Sell
112,147
-338
-0.3% -$45.4K 0.6% 46
2022
Q2
$17.2M Buy
112,485
+23,097
+26% +$3.54M 0.65% 44
2022
Q1
$14.5M Buy
89,388
+114
+0.1% +$18.5K 0.46% 67
2021
Q4
$12.1M Buy
89,274
+50,135
+128% +$6.79M 0.36% 85
2021
Q3
$4.22M Buy
39,139
+27,492
+236% +$2.97M 0.14% 178
2021
Q2
$1.31M Sell
11,647
-24,346
-68% -$2.74M 0.04% 277
2021
Q1
$3.9M Sell
35,993
-1,781
-5% -$193K 0.14% 188
2020
Q4
$4.05M Sell
37,774
-2,575
-6% -$276K 0.15% 173
2020
Q3
$3.53M Sell
40,349
-10,118
-20% -$886K 0.16% 165
2020
Q2
$4.95M Buy
50,467
+16,111
+47% +$1.58M 0.23% 129
2020
Q1
$2.62M Buy
34,356
+1,731
+5% +$132K 0.15% 175
2019
Q4
$2.89M Sell
32,625
-459
-1% -$40.6K 0.13% 207
2019
Q3
$2.51M Buy
+33,084
New +$2.51M 0.12% 217
2018
Q4
Sell
-23,305
Closed -$2.2M 364
2018
Q3
$2.2M Hold
23,305
0.14% 212
2018
Q2
$2.16M Sell
23,305
-14,992
-39% -$1.39M 0.14% 204
2018
Q1
$3.62M Sell
38,297
-21,871
-36% -$2.07M 0.24% 127
2017
Q4
$5.82M Sell
60,168
-16,424
-21% -$1.59M 0.38% 67
2017
Q3
$6.81M Sell
76,592
-29
-0% -$2.58K 0.42% 56
2017
Q2
$5.56M Sell
76,621
-23,000
-23% -$1.67M 0.38% 62
2017
Q1
$6.49M Buy
99,621
+2,483
+3% +$162K 0.44% 47
2016
Q4
$6.08M Sell
97,138
-14,162
-13% -$887K 0.42% 52
2016
Q3
$7.02M Buy
+111,300
New +$7.02M 0.49% 45